Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Alkami Announces First Quarter 2021 Financial Results
Alkami Technology, Inc.May 11, 2021 GMT
PLANO, Texas, May 11, 2021 (GLOBE NEWSWIRE) Alkami Technology, Inc. (Nasdaq: ALKT) (“Alkami”), a leading cloud-based digital banking solutions provider for U.S.-based financial institutions, announced today results for its first quarter ending March 31, 2021.
First Quarter 2021 Financial Highlights
GAAP total revenue of $33.3 million, an increase of 43% year-over-year;
GAAP gross margin of 53.4%, an expansion of nearly 470 basis points year-over-year;
Non-GAAP gross margin of 54.5%, an expansion of approximately 540 basis points year-over-year;
GAAP net loss of ($10.9) million compared to a net loss of ($10.3) million in the prior year; and,
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
GSK and Vir Biotechnology Announce the Start of the EMA Rolling Review of VIR-7831 .
Vir Biotechnology, Inc.May 7, 2021 GMT
– Rolling review will evaluate sotrovimab in adults and adolescents with COVID-19 who do not require oxygen supplementation and who are at risk of progressing to severe COVID-19 –
– Review will support a formal Marketing Authorization Application –
– GSK and Vir continue discussions with global regulators to make sotrovimab available to patients with COVID-19 –
LONDON and SAN FRANCISCO, May 07, 2021 (GLOBE NEWSWIRE) GlaxoSmithKline plc (LSE/NYSE: GSK) and Vir Biotechnology, Inc. (Nasdaq: VIR) today announced that the European Medicines Agency (EMA) has started a rolling review of data on sotrovimab (previously VIR-7831), an investigational dual-action SARS-CoV-2 monoclonal antibody, for the treatment of adults and adolescents (aged 12 years and o
Adient reports solid second quarter 2021 financial results despite a turbulent production environment
Transformational change to the company s capital structure underway, underpinned by accelerated debt repayment
News provided by
Share this article
Share this article
PLYMOUTH, Mich., May 6, 2021 /PRNewswire/ Adient (NYSE: ADNT), a global leader in automotive seating, today announced second quarter 2021 financial results.
Q2 GAAP net income and EPS diluted of $69M and $0.72 respectively; Q2 Adj.-EPS diluted of $1.15
Q2 Adj.-EBITDA of $303M, up $92M y-o-y; Q2 Adj. EBITDA margin of 7.9%, up 190 bps y-o-y
Cash and cash equivalents of $984M at March 31, 2021 (cash used during the quarter to voluntarily pay down debt totaled ~$700M)
COVID-19
Trisura staff continue to work effectively from home. We have introduced safety measures in physical offices and began a gradual return to work in jurisdictions where it is safe.
Despite resilience in the quarter, a recent third wave globally and the potential for a weaker than anticipated economic recovery may threaten momentum.
Premium generation and claims activity may be impacted depending on the length and depth of the pandemic-related economic slowdown, as well as the effectiveness of government support programs and vaccines in driving a sustained re-opening. Depending on these factors, premium growth could slow and claims activity could increase.
Press release content from Business Wire. The AP news staff was not involved in its creation.
Aspen Appoints Laurie Shane as Group Head of Outwards Reinsurance
May 6, 2021 GMT
HAMILTON, Bermuda (BUSINESS WIRE) May 6, 2021
Laurie Shane joins Aspen Insurance Holdings Limited (“Aspen”) as new Group Head of Outwards Reinsurance and begins her role on June 1, 2021. Laurie will report to Brian Tobben, CEO Aspen Capital Partners.
Laurie joins Aspen from Markel Corporation where she was Managing Director of Global Ceded Reinsurance. In this role she worked to develop outward reinsurance strategies focusing on reducing group earnings volatility, balance sheet protection and managing third party credit risk.